跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL
Approved
THERAPEUTIC
VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL
Astellas Pharma Inc. (Yaizu Technology Center) (JAPAN)
🇸🇬 Health Sciences Authority
Approval Date
Aug 24, 2026
Approval ID
aff97c953f7c1d3a
Company
Astellas Pharma Inc. (Yaizu Technology Center) (JAPAN)
Type
Therapeutic
Approval Details
Approval Id
aff97c953f7c1d3a
Drug Name
VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL
Product Name
VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL
Approval Number
SIN17625P
Approval Date
2026-08-24
Registrant
ASTELLAS PHARMA SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 24, 2026
Approval ID
aff97c953f7c1d3a
Type
Therapeutic
Back to HSA Approvals